Lv5
1068 积分 2025-04-17 加入
The Next Generation of Antibody Drug Conjugates
2小时前
待确认
Preclinical pharmacokinetics of MEHD7945A, a novel EGFR/HER3 dual-action antibody, and prediction of its human pharmacokinetics and efficacious clinical dose
3小时前
待确认
Mechanistic modeling suggests stroma-targeting antibody-drug conjugates as an alternative to cancer-targeting in cases of heterogeneous target expression
5天前
已完结
CRISPR–Drug Combinatorial Screening Identifies Effective Combination Treatments for MTAP -Deleted Cancer
8天前
已完结
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP -Deleted KRAS -Mutant Pancreatic Cancer
8天前
已完结
MTAP Deletion in Oncogenesis: A Synthetic Lethality Scenario
9天前
已完结
Data from Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
13天前
已完结
Targeting LRRC15 in Cancer-Associated Fibroblasts Modifies the Extracellular Matrix and Enhances Tumor Immune Responses to Suppress Lung Cancer Progression
13天前
已完结
LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity
13天前
已完结
Second generation transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase
15天前
已完结
皖公网安备34019202002308
